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Nitrates are the most frequently prescribed and utilized drugs worldwide. The elderly are a major population receiving nitrate
therapy. Both nitrates and aging can increase in vivo reactive oxygen species (ROS) and reactive nitrogen species (RNS). To
date, the effects of aging upon nitrate-induced ROS/RNS alteration are unknown. The present study tested the effects of aging
upon nitrate-induced ROS/RNS alteration in vivo. 32 adults and 43 elderly unstable angina (UA) patients were subjected to 48
hours of isosorbide dinitrate intravenous injection (50 𝜇g/minutes) in this clinical study. Blood samples were obtained at baseline
and conclusion. Outcome measures of oxidative stress included plasma malondialdehyde (MDA), myeloperoxidase (MPO), and
reduced glutathione (GSH). Plasma concentrations of NOx and nitrotyrosine served as markers of RNS. Because of the significant
differences in basic clinical characters between adults and the elderly, we designed an additional experiment determining ROS/RNS
stress in rat cardiac tissue. Additionally, rat thoracic aortic NOS activity served as a marker indicating endothelial function. Our
study demonstrated that nitrate therapy significantly increased in vivo ROS/RNS stress in the elderly compared to adult patients,
confirmed by animal data. Decreased NOS activity was observed in old rats. Taken together, the present study’s data suggests a
synergism between nitrate treatment and the aging process.

1. Introduction
Rapid growth of the world’s geriatric population has
increased awareness of age-related cardiovascular diseases.
Cardiovascular diseases are responsible for the majority of
elderly mortality. 80 percent of patients with ischemic heart
disease are ≥65 years old [1]. Organic nitrates have been
employed in the treatment of ischemic heart disease for more
than a century and remain the most frequently prescribed and
utilized medications for treating the ischemic heart disease
population worldwide, of which the elderly are a major
constituent.
The process of aging is complex. Senescent pathophysiology arises from various factors through multiple mechanisms. Harman proposed the free radical theory of aging in
the 1950s, expanding to implicate mitochondrial production
of reactive oxygen species in the 1970s [2]. Per this theory,

enhanced and unopposed metabolism-driven oxidative stress
plays a major role in diverse chronic age-related disorders
[3, 4]. In the free-radical theory of aging, organisms age
because their cells accumulate free radical damage over
time. In our previous study, aging resulted in significantly
increased reactive oxygen species (ROS) and reactive nitrogen species (RNS) after myocardial infarction [5, 6]. Nitrate
therapy also augments ROS and RNS production. In 1995,
Munzel et al. [7] demonstrated that in vivo nitrate use
was associated with an endothelial-dependent production of
superoxide anion, an important mechanistic development in
the understanding of nitrate tolerance. Munzel’s work was
further supported by the association of reduced superoxide
anion production with inclusion of a nitrate-free period in
vivo [8]. A randomized controlled trial (RCT) of patients
undergoing elective coronary artery bypass grafting subjected
to preoperative intravenous nitroglycerin (GTN) confirmed

2
increased superoxide generation in internal mammary artery
samples after nitrate treatment [9].
Substantial evidence supports oxidative stress as one
of the major etiologies of myocardial injury. Numerous
experiments have demonstrated markedly increased superoxide (O2 − ) generation from ischemic/reperfused endothelial cells and increased neutrophil activation in postischemic
myocardial tissue. O2 − further dismutates to H2 O2 and
∙
OH, the latter highly toxic to biological tissues, causing
significant myocardial necrosis and apoptosis. Additionally,
accumulating evidence indicates RNS, such as peroxynitrite
(ONOO− ), play vital roles in reperfusion-induced myocardial
apoptosis [10]. The deleterious effects of RNS are further
exacerbated by interaction with increased ambient ROS.
Most studies investigating nitrate use have employed young
animals. Although it is well known that both aging and
nitrates increase in vivo ROS/RNS production; heretofore,
the effects of nitrate administration in the aged population
remain unknown.
The present study determined whether nitrates increase
in vivo ROS/RNS concentrations in a clinical trial. Limitations of our study included clinical and demographic
characteristic (blood pressure, diabetes, and past medical history) discrepancies between middle-aged and elderly patients
and inability to obtain cardiac tissue samples from enrolled
participants. A carefully controlled experiment upon rats was
therefore included in the present study.

2. Materials and Methods
The clinical trial was carried out in accordance with the
Declaration of Helsinki (2000) of the World Medical Association. The study protocol was approved by the institutional
ethics committee of the Beijing Anzhen Hospital-Affiliate
of Capital Medical University. After full disclosure of the
study’s purpose, nature, and inherent risks of participation, all
subjects gave written informed consent prior to enrollment.
2.1. Inclusion and Exclusion Criteria of Acute Myocardial
Infarction Patients. Unstable angina (UA) patients met inclusion criteria if the following conditions were true: (1) presence
of typical angina, (2) presence of electrocardiographic S-T
segment changes (representative of cardiac injury) during
clinical chest pain, or (3) presence of the significant coronary
stenosis (≥75%) diagnosed by either computed tomography
coronary angiography (CTCA) or coronary angiography.
Exclusion criteria for this study included (1) increasing
myocardial necrotic marker (cTnI or CKMB) levels; (2)
cardiogenic shock; (3) occlusion or severe stenosis of the left
main coronary artery; (4) previous myocardial infarction; (5)
major infection or surgery within the past 2 weeks prior to
presentation.
2.2. Coronary Angiography and Clinical Experimental Design.
In present study, isosorbide dinitrate was used in the clinical
trial and nitroglycerin was used in the animal experiment.
Both of them are nitrates. Nitrates correct the imbalance
between the flow of blood and oxygen to the heart and
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the work that the heart must do by dilating (expanding) the
arteries and veins in the body. Dilation of the veins reduces
the amount of blood that returns to the heart that must be
pumped. Dilation of the arteries lowers the pressure in the
arteries against which the heart must pump. As a consequence
of both effects, the heart works less and requires less blood
and oxygen.
All UA patients were given standard UA treatment protocol. Patients were divided into two groups: (1) adult patients
(<65 years) and (2) elderly patients (≥65 years).
All patients received intravenous isosorbide dinitrate
(50 𝜇g/minute) treatment. Blood samples were obtained
before and after 48 hours of nitrate treatment.
2.3. Animal Experiment Protocol. The study was approved by
the institutional ethics committee and was in accordance with
the United States National Institutes of Health guidelines.
Male Sprague-Dawley rats were anesthetized with sodium
pentobarbital. The rat model was described previously [5,
8, 11]. In brief, male Sprague-Dawley rats (aged either 8
weeks (young) or 24 months (old)) were anesthetized with
sodium pentobarbital (50 mg/kg body weight) intravenously.
An intratracheal tube was inserted via midline midline
incision. All rats were given intermittent positive-pressure
ventilation with oxygen-enriched room air via Harvard small
animal respirator (Harvard Apparatus, South Natick, MA).
A transfusion needle was inserted into the caudal vein for
supplemental pentobarbital injection to maintain anesthesia
and for drug administration. Rats (8 weeks or 24 months
old) were divided into the following four groups: (1) sham
young; (2) sham old; (3) young; and (4) old (𝑛 = 12 each).
Vehicle (1 mL/kg/h) or nitroglycerin (60 𝜇g/kg/h) [8] was
continuously infused for 12 hours. Sham rats received vehicle
solution only. After 12 hours of vehicle or nitroglycerin infusion, animals were sacrificed. Cardiectomies were performed.
2.4. Quantitative Evaluation of Reactive Oxygen Species (ROS)
Level in Humans and Rats. To determine the effects of aging
upon in vivo ROS, malondialdehyde (MDA), myeloperoxidase (MPO), and reduced glutathione (GSH) served as
oxidative stress markers.
Blood samples were drawn from UA patients after 0
and 48 hours of injection. Blood samples were immediately
centrifuged at 10000 RPM for 1 minute at 4∘ C. Supernatant
was collected and stored at −80∘ C until measurement.
Plasma malondialdehyde (MDA), myeloperoxidase (MPO),
and reduced glutathione (GSH) concentrations were detected
by commercially available kits, as reported previously [11].
Plasma MDA, MPO, and reduced GSH concentrations
do not directly reflect oxidative stress within cardiac tissue.
Therefore, MDA, MPO, and reduced GSH concentrations in
rat cardiac tissue were measured. After 12 hours injection
or either nitrate or vehicle, left ventricular samples were
homogenized and centrifuged for 30 minutes at 10000 PRM
at 4∘ C. Supernatant protein concentrations were measured
by the bicinchoninic acid method. MDA, MPO, and reduced
GSH concentrations were determined.
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Eligible patients:
unstable angina patients without PCI treatment
n = 86
Criteria for grouping
Adult: <65 years
Old: ⩾65 years
Two groups in the study:
(1) adult UA patients (<65 years, n = 33)
(2) old UA patients (⩾65 years, n = 53).
Excluded (total = 11):
refuse to participate after enrollment:
adult UA patients n = 1
old AMI patients n = 2
Side effects:
old UA patients n = 8
Data available for analysis:
(1) adult UA patients (<65 years, n = 32)
(2) Old UA patients (⩾65 years, n = 43)

Figure 1: The grouping of clinical trial.

2.5. Quantitative Evaluation of Reactive Nitrogen Species
(RNS) Level in Humans and Rats. NOx (nitrite and nitrate,
the stable metabolites of NO) quantity in supernatants was
determined via Griess reaction utilizing a NOx concentration
assay kit (R and D Systems Inc., Minneapolis, MN). Rat
cardiac tissues were harvested and similarly processed as
described above.
Nitrotyrosine is the accepted footprint of in vivo ONOO−
formation. Nitrotyrosine concentration of both rat cardiac
tissue homogenate and patient plasma was determined
via ELISA kit (Cell Sciences Inc., Canton, MA, USA), as
previously described, reported as nanomoles of nitrotyrosine/gram of tissue protein homogenate or nanomoles of
nitrotyrosine/liter plasma.
2.6. The Assay of NOS Activity in Rat Thoracic Aorta.
Under physiological conditions, rat thoracic aortic NOS
activity indirectly reflects vascular eNOS concentrations
and endothelial function. Therefore, in the present study,
NOS activity in rat thoracic aorta served as a marker of
endothelial function. After 12 hours of nitrate administration,
rat thoracic aortae were isolated and harvested. Samples were
homogenized and centrifuged for 30 minutes at 12,000 g at
4∘ C. Supernatant protein concentrations were measured by
the bicinchoninic acid method. Methods determining NOS
activity have been described previously.
2.7. Statistical Analysis. All values are presented as means ±
SEM. All biochemical assays were performed in duplicate
and averaged. Data were subjected to ANOVA, followed
by Bonferroni correction for post hoc Student’s 𝑡-tests. All
statistics were calculated utilizing Graphpad Prism 5.0. 𝑃
values <0.05 were considered statistically significant.

3. Results
3.1. Patient Population Demographics and Characteristics. 33adult UA patients and 53 elderly UA patients were enrolled in
the clinical trial. Of 86 patients, 1 adult and 2 elderly patients
refused participation after enrollment and 8 elderly patients
discontinued participation due to side effects (Figure 1).
Table 1 lists all demographic data, baseline statistics, cardiovascular risk profile, and medication profiles of patients.
The major differences between the adult and elderly patient
populations involved gender distribution and past medical
history.

3.2. Aging Increased Oxidative Stress in Human Plasma
after 48 Hours Nitrate Treatment. To determine the effects
of aging upon plasma ROS levels after nitrate injection,
plasma levels of MDA, MPO, and reduced GSH (markers
reflecting myocardial oxidative stress) at two distinct time
points (before and after 48 hours nitrate treatment) were
determined. Plasma MDA and MPO concentration in elderly
UA patients were significantly increased before and after
nitrate administration compared to adult patients (Figures
2(a) and 2(b)). Nitrates increased plasma MDA by 140% in the
elderly group. Nitrates increased plasma MDA by 60% in the
adult group (Figure 2(a)). Nitrates increased plasma MPO by
50% in the elderly group, compared to 20% in the adult group.
Glutathione is one of the most important physiologic selfgenerating antioxidants. To indirectly evaluate in vivo oxidative stress burden, we determined the plasma concentrations
of reduced-form GSH. In consistent trend with plasma
MDA and MPO data, elderly patients manifested reduced
GSH concentrations compared to adult patients, which further decreased after nitrate administration (Figure 2(c), 48%
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Table 1: Baseline Characteristics of the Study Population (mean ± SD).

Age, y
Sex, M/F
HBP/total
Dyslipidemia/total
Diabetes/total
Smoker/total
Past drug treatment (𝑛/total)
Statins
Calcium channel blocker
ACEI
ß-Adrenoceptor blocker
Diuretic
Drug treatment during the study (𝑛/total)
Statins
Calcium channel blocker
ACEI
ß-Adrenoceptor blocker
nitrates
Mean dosage of nitrates (𝜇g/min)

MI adult (𝑛 = 34)
50.1 ± 6.6
28/4
23/32
21/32
20/32
24/32

MI elderly (𝑛 = 45)
73.7 ± 4.8
24/19
35/43
34/43
29/43
29/43

𝑃
<0.001
<0.01
NS
NS
NS
NS

17/32
9/32
15/32
8/32
5/32

30/43
18/43
31/43
26/43
20/43

NS
NS
<0.05
<0.01
<0.01

32/32
19/32
17/32
21/32
32/32
50

43/43
32/43
27/43
27/43
43/43
50

NS
NS
NS
NS
NS
NS

HBP indicates high blood pressure; ACEI: angiotensin-converting enzyme inhibitor; y: year; M: male; F: female.

reduction of elderly plasma GSH after nitrates, compared to
9% reduction in adult patients).
3.3. Aging Increased Oxidative Stress in Rat Cardiac Tissue
with 12-Hour Nitrate Treatment. Furthermore, in vivo study
results confirm the results from clinical trial. Nitrate administration significantly increased rat myocardial MDA and MPO
concentrations and decreased myocardial reduced-GSH level
in the old group (Figures 2(d), 2(e), and 2(f)).
3.4. Aging Increased Plasma NOx or Nitrotyrosine Concentrations in Humans after 48-Hour Nitrate Treatment. RNS
(reactive nitrogen species) play a critical pathogenic role
in mediating myocardial injury. NO reacts with superoxide
(whose production is increased with aging) to form the toxic
molecule peroxynitrite (ONOO− ), a strongly nitrating and
oxidizing agent. ONOO− substantially induces myocardial
apoptosis. We determined both plasma NOx and nitrotyrosine concentrations in the present study. There were no
significant differences in plasma NOx concentration between
adult and elderly patients before nitrate administration.
Baseline plasma nitrotyrosine concentration is significantly
greater in the elderly than adult population. 48 hours of
nitrate injection significantly increased plasma NOx (250%
in the elderly compared to 150% in the adult patients) and
nitrotyrosine (210% in the elderly compared to 105% in the
adult patients) concentrations (Figures 3(a) and 3(c)).
3.5. Aging Increased Cardiac NOx and Nitrotyrosine Concentrations in Rats after 12-Hour Nitrate Treatment. To confirm
the effects of aging upon RNS formation, we determined NOx

and nitrotyrosine concentrations in a rat model after nitrate
administration. As shown in Figures 3(b) and 3(d), 12 hours
of nitrate infusion significantly increased cardiac NOx and
nitrotyrosine concentrations in both the young and old rat
groups. In the elderly group, NOx concentrations increased
255%, compared to 170% in the young group. Similarly,
cardiac nitrotyrosine concentrations increased 78% in the old
rats, compared to 22% in the young rats.
3.6. Aging Increased NOS Activity in Rat Thoracic Aorta after
12-Hour Nitrate Treatment. Both eNOS activity and nitric
oxide bioavailability are vital markers indicating endothelial
function. Rat thoracic aorta NOS activity served as an
indirect index of eNOS activity and endothelial function. As
shown in Figure 4, 12 hours of nitrate infusion significantly
decreased NOS activity in both young and old rat thoracic
aortae. 45% decreased NOS activity was observed in the
elderly group, compared to 18% decrease in the young group,
suggesting that nitrates induced more severe endothelial
dysfunction in the elderly state.

4. Discussion
Several novel observations have been made in the present
study. Firstly, we demonstrate for the first time with clinical
data that nitrate treatment may increase oxidative/nitrative
stress burden in the elderly. To our knowledge, previous
investigations demonstrating nitrates increased ROS/RNS
post I/R involved all young animals, heretofore unconfirmed
in human studies. Secondly, although endothelial function
depression has been observed after nitrate administration,
our results suggest that aging exacerbated such effects.
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Figure 2: Aging was associated with increased ROS (MDA and MPO) and decreased reduced glutathione (GSH) after nitrates use. (a)
Plasma malondialdehyde (MDA) concentration was higher in old patients than in adult patients; (b) plasma-reduced glutathione (GSH)
concentration was lower in old patients than in adult patients; and (c) plasma myeloperoxidase (MPO) concentration was greater in elderly
than adult patients. (d), (e), and (f) indicated aging was associated with increased ROS (MDA and MPO) and decreased reduced GSH in rat
cardiac tissue after 12 hours nitrates use. Adult indicates adult group, and elderly indicates elderly group. Totals for the following groups: 32
adult patients; 43 elderly patients. Sham indicates sham group; young and old indicate rats receiving nitrates treatment. In animal experiment,
𝑛 = 12 per group. Data are expressed as mean ± SEM. ∗∗∗ 𝑃 < 0.001 versus adult group. 𝑛 = 12 per group. Data are expressed as mean ± SEM.
∗
∗∗
𝑃 < 0.05, 𝑃 < 0.001 versus young group.
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Figure 3: The effects of aging on nitrates-induced NOx and nitrotyrosine content change in patients plasma and rats cardiac tissue. (a)
indicated the effects of aging on patients plasma NOx content; (b) rats cardiac tissue NOx content; (c) patients plasma nitrotyrosine
concentration; and (d) rats cardiac tissue nitrotyrosine concentration. Nitrates were used in patients for 48 h and in rats for 12 h. Sham
indicates sham group; young and old indicate rats receiving nitrates treatment. 32 adult patients and 43 elderly patients were included in the
trial. In animal experiment, 𝑛 = 12 per group. Data are expressed as mean ± SEM. ∗∗∗ 𝑃 < 0.001 versus young/adult group.

Recent evidence suggests that the mitochondrial respiratory chain is the primary source of nitrate-induced vascular O2 − overproduction, leading to subsequent activation
of vascular nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase, and which mediates the majority of
nitrate tolerance and endothelial dysfunction [12]. The superoxide anion is normally scavenged by various intracellular
and extracellular mechanisms. Superoxide excess may overcome these compensatory mechanisms and rapidly react with
NO (derived in nitrate-dependent fashion) to form toxic peroxynitrite [8, 13]. While the current study confirms the above
principles, we provide data suggesting aging may augment
nitrate-induced superoxide/peroxynitrite generation. Previously, we demonstrate that aging exacerbated reperfusioninduced myocardial injury [6], particularly apoptosis. It is

widely accepted that superoxide anion/peroxynitrite exert
severely deleterious myocardial effects. It is possible that
nitrate-induced ROS/RNS alteration is an important cause of
aging-related myocardial injury.
As a major predictor of cardiac events in patients with
coronary artery disease and heart failure, endothelial dysfunction may be the pathologic sequelae of nitrate [14,
15]. Endothelial dysfunction generally reflects reduced nitric
oxide bioavailability, due to increased oxidative/nitration
stress. Aging is an independent risk factor of cardiovascular
diseases such as myocardial infarction and heart failure.
Nitrate administration increased in vivo RNS and ROS production, furthermore decreasing nitric oxide bioavailability.
The present study indirectly demonstrated aging significantly
exacerbated nitrate-induced endothelial dysfunction, both

NOS activity in thoracic aorta
(pmole citruline/min/mg protein)

Oxidative Medicine and Cellular Longevity
0.11
0.10
0.09
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0.00

7

∗∗∗

Pre
12 h
Time after nitrates treatment
Sham young
Young

Sham old
Old

Figure 4: In rats experiment, 12 h nitroglycerin use resulted in the
depressing of NOS activity in aorta. Sham indicates sham group;
young and old indicate rats receiving nitrates treatment. Data are
expressed as mean ± SEM. ∗∗∗ 𝑃 < 0.001 versus young group.

in human and animals. Our results give insight to the
contribution of aging to cardiovascular injury.
In summary, the elderly is a population treated extensively by nitrates. However, the effects of aging on nitrates use
seem to be neglected. With supporting clinical human data
and experimental animal data, the present study suggests a
deleterious “synergism” between aging and nitrate treatment
upon cardiovascular injury. Aging increases ROS/RNS after
nitrate treatment, which may result in more severe myocardial injury. The current study’s data warrants further studies
investigating the use of nitrates in the elderly, with caveats
regarding its judicious employment.
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